Alex uses his scientific and business experience to support researchers through the process of commercializing candidate therapeutics, from drug discovery through optimization, validation, and commercialization. He performs complex analyses to identify market demand and clinical impact for prospective therapeutics. Alex has experience working in the fields of oncology, infectious disease, transplant medicine, and genetics/genomics. Alex has a B.S. in Biology from Pacific Lutheran University in Tacoma, WA. He earned his Ph.D. in Oncological Sciences from the University of Utah School of Medicine.